Loading…
Carlsmed, Inc. is projected to rise to $11.97 by 2027, a +2% move from its current price of $11.72. CARL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $11.33 | $11.72 | $12.13 | 0.00% |
| May 30 | $11.17 | $11.72 | $12.30 | 0.00% |
| May 31 | $11.05 | $11.72 | $12.43 | 0.00% |
| Jun 1 | $10.95 | $11.72 | $12.55 | 0.00% |
| Jun 2 | $10.86 | $11.72 | $12.65 | -0.01% |
| Jun 3 | $10.78 | $11.72 | $12.74 | -0.01% |
| Jun 4 | $10.71 | $11.72 | $12.82 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.71 | $11.72 | $12.82 | -0.01% |
| Week 2 | $10.32 | $11.72 | $13.31 | -0.01% |
| Week 3 | $10.02 | $11.72 | $13.70 | -0.02% |
| Week 4 | $9.78 | $11.72 | $14.03 | -0.03% |
| Week 5 | $9.58 | $11.72 | $14.33 | -0.04% |
| Week 6 | $9.39 | $11.72 | $14.61 | -0.04% |
| Week 7 | $9.23 | $11.71 | $14.87 | -0.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. Its operations include the aprevo platform, a comprehensive technology for spine fusion procedures that combines proprietary surgical planning software, outcomes-based algorithms aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants.
The company was incorporated in 2018 and is based in Carlsbad, California. It operates in the Healthcare sector, focused on advancing spine surgery through AI-enabled solutions.
Carlsmed is publicly traded under the CARL symbol and is described here through its product platform, corporate basics, and market metrics provided in the verified data.
Carlsmed, Inc. (CARL) is a healthcare stock with a current price of $12.11 and a market capitalization of $329.21M, ranking 3430 by market cap. The stock shows bullish technical sentiment in the near term, reflecting momentum in its price action.
Key levels include a 30-day range from $9.56 to $15.35, with an RSI(14) of 70, a SMA50 of $10.23, and a SMA200 of $12.42. Support sits at $8.83 and resistance at $12.65, suggesting defined downside and upside boundaries in the near term.
Looking ahead, the forecast list shows higher average prices in the years beyond 2026, with 2030, 2040, and 2050 predicting materially higher averages and positive ROI levels, underscoring a longer-term bullish outlook for the asset.
A major floor 38.2% below — a decisive break under it would weaken the trend.
The nearest floor, 24.7% below — buyers have tended to step in here.
The nearest ceiling, 7.9% above — a clean break opens room to run.
A major ceiling 27.0% above — clearing it would confirm fresh momentum.
Key CARL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CARL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.03 | Sell | $11.79 | Sell |
| MA 10 | $11.44 | Buy | $11.43 | Buy |
| MA 20 | $10.42 | Buy | $10.92 | Buy |
| MA 50 | $10.24 | Buy | $10.75 | Buy |
| MA 100 | $11.37 | Buy | $11.26 | Buy |
| MA 200 | $12.41 | Sell | $12.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.46 | Neutral |
| Stoch RSI (14) | 51.76 | Neutral |
| CCI (20) | 83.76 | Neutral |
| Williams %R (14) | -31.10 | Info |
| MACD (12,26,9) | 0.22 | Buy |
| ROC (12) | 19.59 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 68.90 | Neutral |
| TRIX (15) | 0.40 | Buy |
| Awesome (5,34) | 1.69 | Buy |
| Ultimate (7,14,28) | 64.40 | Neutral |
| Momentum (10) | 1.89 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 12.31 | Sell |
| ADX (14) | 20.30 | Buy |
| ATR (14) | 0.35 | Info |
Near-term sentiment is bullish, supported by an RSI(14) of 70. The price is above the 50-day simple moving average of $10.23 and is near the 200-day average of $12.42, indicating constructive momentum.
The stock shows a defined near-term support at $8.83 and resistance at $12.65. The 30-day trading range spans from $9.56 to $15.35, illustrating recent volatility within a bounded corridor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.83 | $11.72 | $14.99 | 0% | Neutral | |
| $8.78 | $11.97 | $17.61 | +2% | Neutral | |
| $8.67 | $12.45 | $19.39 | +6% | Neutral | |
| $8.15 | $12.25 | $19.94 | +5% | Neutral | |
| $9.67 | $15.13 | $25.55 | +29% | Bullish | |
| $11.26 | $18.31 | $31.92 | +56% | Bullish | |
| $11.61 | $19.58 | $35.10 | +67% | Bullish | |
| $11.10 | $19.37 | $35.63 | +65% | Bullish | |
| $10.60 | $19.13 | $36.02 | +63% | Bullish | |
| $11.13 | $20.76 | $39.94 | +77% | Bullish | |
| $14.54 | $31.74 | $66.70 | +171% | Bullish | |
| $25.05 | $55.66 | $128.03 | +375% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.83 | $11.72 | $13.84 | +0.00% |
| June 2026 | $9.61 | $11.47 | $14.17 | -2.09% |
| July 2026 | $9.66 | $11.71 | $14.80 | +2.04% |
| August 2026 | $9.46 | $11.60 | $14.93 | -0.89% |
| September 2026 | $8.90 | $11.03 | $14.39 | -4.96% |
| October 2026 | $8.73 | $10.92 | $14.42 | -1.04% |
| November 2026 | $8.89 | $11.21 | $14.98 | +2.74% |
| December 2026 | $8.73 | $11.10 | $14.99 | -1.03% |
Click any year to see its month-by-month CARL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CARL price prediction for 2026 points to an average of $11.72 (low $8.83, high $14.99) — a potential gain of 0% on today's $11.72. A consolidation phase looks the most probable path here.
In 2027, CARL is projected to trade between $8.78 and $17.61, averaging $11.97 — a potential gain of +2% from today's $11.72. That is up +2% on the projected 2026 average. Price action looks broadly range-bound.
Carlsmed, Inc.'s 2028 outlook centres on $12.45, within a $8.67 to $19.39 range. That is up +4% on the projected 2027 average. That marks a +6% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, CARL could reach as high as $19.94, with a base case around $12.25 and support toward $8.15 — roughly +5% from $11.72. Price action looks broadly range-bound.
Expect CARL to range from $9.67 to $25.55 through 2030. The $15.13 average target implies a +29% move from current prices. That is up +23% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The CARL price prediction for 2031 points to an average of $18.31 (low $11.26, high $31.92) — a potential gain of +56% on today's $11.72. Momentum favours further upside here.
In 2032, CARL is projected to trade between $11.61 and $35.10, averaging $19.58 — a potential gain of +67% from today's $11.72. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Carlsmed, Inc.'s 2033 outlook centres on $19.37, within a $11.10 to $35.63 range. That is -1% versus the projected 2032 average. That marks a +65% change versus current levels. Momentum favours further upside here.
By 2034, CARL could reach as high as $36.02, with a base case around $19.13 and support toward $10.60 — roughly +63% from $11.72. Buyers look set to stay in control over this stretch.
Expect CARL to range from $11.13 to $39.94 through 2035. The $20.76 average target implies a +77% move from current prices. That is up +9% on the projected 2034 average. Momentum favours further upside here.
The CARL price prediction for 2040 points to an average of $31.74 (low $14.54, high $66.70) — a potential gain of +171% on today's $11.72. Buyers look set to stay in control over this stretch.
In 2050, CARL is projected to trade between $25.05 and $128.03, averaging $55.66 — a potential gain of +375% from today's $11.72. That is up +75% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CARL today (≈ 85.324232 CARL) could be worth
$4,749.47
+$3,749.47 (+375%) by 2050 · US Dollar
Based on the average projected CARL price of $55.66 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CARLwould be worth at today's price.
$1,000 invested in CARL on Jul 23, 2025 (≈ 68.965517 CARL) would be worth
$808.28
-$191.72 (-19.2%) today · 0.81× · US Dollar
Based on a CARL entry price of $14.5 vs. today's $11.72.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.77 | $995.75 | -0.4% |
| 1 month ago | $9.86 | $1,188.64 | +18.9% |
| 3 months ago | $14.56 | $804.95 | -19.5% |
| 6 months ago | $16.28 | $719.9 | -28.0% |
| All time ago | $14.5 | $808.28 | -19.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CARL forecast.
Our base-case forecast reaches $23.00 around 2040.
Implied market cap at $23.00: $625.25M
The multi-year forecast envisions a bullish path beyond 2026, with 2030 showing an average price of $15.68 and ROI of 29.5, in a bullish outlook. The 2031–2035 period maintains a bullish tilt, with 2031 average $19.06 (ROI 57.4), 2032 average $20.04 (ROI 65.5), 2033 average $20.00 (ROI 65.2), 2034 average $19.70 (ROI 62.7), and 2035 average $21.14 (ROI 74.6).
By 2040, the average is forecast at $32.65 with a max of $70.43 and ROI of 169.6, and by 2050 the average is forecast at $57.09 with a max of $131.30 and ROI of 371.4. These figures indicate substantial upside potential in the long run, though they are estimates and not guarantees. Investors should consider the inherent uncertainty and the potential for volatility in line with the asset’s historical price dynamics.
Tap a question to reveal the answer.
2030 average price $15.68, min $9.80, max $26.97; ROI 29.5; sentiment bullish.
Forecasts show a bullish outlook in 2030 and beyond with higher average prices, while 2026–2029 are neutral. For 2030 the average is $15.68 with upside to $26.97, but these are estimates, not guarantees.
Yes. The forecast max by 2040 is $70.43 and by 2050 is $131.30, so reaching $50 is within the forecast range over the longer term.
2035 average price $21.14, min $10.91, max $41.61; ROI 74.6; sentiment bullish.
Carlsmed, Inc. Community Discussion
0Share your Carlsmed, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.